CAD-CAM TECHNOLOGY FOR DIABETIC FOOTWEAR

描述(申请人摘要)：超过15%的糖尿病患者 (DM)将经历脚部溃疡。这类患者必须穿特殊的鞋 用生命来防止复发。目前设计和制造的是 治疗鞋在很大程度上是基于主观标准。成功 鞋子通常是由经验丰富的工匠制作的，许多款式的鞋子都是 通常是必需的。我们将在研究的两个阶段制定一个完整的 将纳入的针对高危糖尿病患者的治疗鞋系统：数据 鞋垫采集；鞋垫自动算法；制造CAD-CAM系统； 以及用于选择包括鞋底修改的鞋的系统。初步 研究为鞋内成分的分析提供了经验和技术。 足底压力分布，而市场研究表明， 是需要为这个问题提供一个全面的鞋类解决方案。 拟议的商业应用：两种潜在竞争的CAD-CAM产品 正在市场上帮助医生为糖尿病患者设计定制的软件 病人。两者都很昂贵，而DIApedia LLC将把它的系统推向 只有5000美元到10000美元之间。潜在的美国和欧洲市场是 每一个估计都超过2500万美元：日本市场将是 大约是这个数字的一半。全球市场潜力估计为 超过6500万美元。该公司将从每一家公司获得持续的收入流 生产的一双鞋。

DESCRIPTION (Applicant's Abstract): Over 15 percent of diabetic patients (DM) will experience a foot ulcer. Such patients must use special footwear for life to prevent recurrence. Currently the design and manufacture of therapeutic footwear is largely based on subjective criteria. Successful shoes are usually made by experienced craftspeople and many iterations are often required. We will, over both phases of the study, develop an entire therapeutic shoe system for at risk DM patients that will incorporate: data collection; automatic algorithm for insoles; CAD-CAM system for manufacture; and system for shoe selection including outsole modifications. Preliminary studies have provided experience and techniques for the analysis of in-shoe plantar pressure distribution, and market research has indicated that there is a need to provide a comprehensive footwear solution for this problem. PROPOSED COMMERCIAL APPLICATION: Two potentially competing CAD-CAM products are on the market to help physicians design custom footware for diabetic patients. Both are expensive, while DIApedia LLC will market its system for only between $5,000 and $10,000. The potential U.S. and European markets are each estimated to be more than $25 million: the Japanese market would be about half of this amount. The worldwide market potential is estimated to be over $65 million. The company will have an ongoing revenue stream from each pair of shoes that is produced.